{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:39Z","timestamp":1792782639530,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Shanghai Science and Technology Committee Foundation","award":["15411967700"],"award-info":[{"award-number":["15411967700"]}]},{"name":"Shanghai Science and Technology Committee Foundation","award":["16411950200"],"award-info":[{"award-number":["16411950200"]}]},{"DOI":"10.13039\/100007219","name":"Shanghai Natural Science Foundation","doi-asserted-by":"crossref","award":["15ZR1433300"],"award-info":[{"award-number":["15ZR1433300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771529"],"award-info":[{"award-number":["81771529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00404-018-4931-1","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T02:51:08Z","timestamp":1541127068000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Human papillomavirus DNA, HPV L1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression"],"prefix":"10.1007","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-5896","authenticated-orcid":false,"given":"Huiyan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"4931_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijgo.2010.02.011","volume":"110","author":"A Karabulut","year":"2010","unstructured":"Karabulut A, Alan T, Ali Ekiz M, Iritas A, Kesen Z, Yahsi S (2010) Evaluation of cervical screening results in a population at normal risk. Int J Gynaecol Obstet 110:40\u201342. https:\/\/doi.org\/10.1016\/j.ijgo.2010.02.011","journal-title":"Int J Gynaecol Obstet"},{"key":"4931_CR2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518\u2013527","journal-title":"N Engl J Med"},{"key":"4931_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00404-013-3124-1","volume":"289","author":"N Izadi-Mood","year":"2014","unstructured":"Izadi-Mood N, Sarmadi S et al (2014) Immunohistochemical expression of p16 and HPV L1 capsid proteins as predictive markers in cervical lesions. Arch Gynecol Obstet 289:1287\u20131292","journal-title":"Arch Gynecol Obstet"},{"key":"4931_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/jnci\/91.6.506","volume":"91","author":"EL Franco","year":"1999","unstructured":"Franco EL, Rohan TE, Villa LL (1999) Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 91:506\u2013511","journal-title":"J Natl Cancer Inst"},{"key":"4931_CR5","first-page":"83","volume":"133","author":"CJ Meuer","year":"1998","unstructured":"Meuer CJ, Helmerhorst TJ, Rosendaal L, Van Der Lin-Den JC, Voorhorst FJ, Walboomers JM (1998) HPV typing and testing in gynaecological pathology: has the time come? Histopathology 133:83\u201386","journal-title":"Histopathology"},{"key":"4931_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/cncr.23366","volume":"114","author":"T Yoshida","year":"2008","unstructured":"Yoshida T, Sano T, Kanuma T, Owada N, Sakurai S, Fukuda T, Nakajima T (2008) Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions. Cancer 114:83\u201388. https:\/\/doi.org\/10.1002\/cncr.23366","journal-title":"Cancer"},{"key":"4931_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:9\u201312","journal-title":"J Pathol"},{"key":"4931_CR8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ygyno.2007.07.067","volume":"107","author":"M Steben","year":"2007","unstructured":"Steben M, Duarte-Franco E (2007) Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107:S2\u2013S5","journal-title":"Gynecol Oncol"},{"key":"4931_CR9","first-page":"241","volume":"26","author":"H Griesser","year":"2004","unstructured":"Griesser H, Sander H, Hilfrich R, Moser B, Schenck U (2004) Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild\/moderate dysplasia. Anal Quant Cytol Histol 26:241\u2013245","journal-title":"Anal Quant Cytol Histol"},{"key":"4931_CR10","first-page":"497","volume":"51","author":"C Ungureanu","year":"2010","unstructured":"Ungureanu C, Socolov D, Anton G, Mihailovici MS, Teleman S (2010) Immunocytochemical expression of p16INK4a and HPV L1 capsid proteins as predictive markers of the cervical lesions progression risk. Rom J Morphol Embryol 51:497\u2013503","journal-title":"Rom J Morphol Embryol"},{"key":"4931_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ogc.2007.09.004","volume":"34","author":"M Safaeian","year":"2007","unstructured":"Safaeian M, Solomon D, Castle PE (2007) Cervical cancer prevention\u2014cervical screening: science in evolution. Obstet Gynecol Clin North Am 34:739\u2013760","journal-title":"Obstet Gynecol Clin North Am"},{"key":"4931_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ijc.22172","volume":"120","author":"Q Zhang","year":"2007","unstructured":"Zhang Q, Kuhn L, Denny LA, De Souza M, Taylor S, Wright TC Jr (2007) Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests. Int J Cancer 120:351\u2013356","journal-title":"Int J Cancer"},{"key":"4931_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000326491","volume":"47","author":"P Melsheimer","year":"2003","unstructured":"Melsheimer P, Kaul S, Dobeck S, Bastert G (2003) Immunocy-tochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta Cytol 47:124\u2013128","journal-title":"Acta Cytol"},{"key":"4931_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/IGC.0b013e3181cd184c","volume":"20","author":"YS Choi","year":"2010","unstructured":"Choi YS, Kang WD, Kim SM, Choi YD, Nam JH, Park CS, Choi HS (2010) Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intra-epithelial neoplasia. Int J Gynecol Cancer 20:288\u2013293. https:\/\/doi.org\/10.1111\/IGC.0b013e3181cd184c","journal-title":"Int J Gynecol Cancer"},{"key":"4931_CR15","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/S0959-8049(02)00462-8","volume":"38","author":"Doeberitz M Knebel Von","year":"2002","unstructured":"Von Knebel Doeberitz M (2002) New markers for cervical dysplasia to visualise the genomic chaos created by aberrant onco-genic papillomavirus infections. Eur J Cancer 38:2229\u20132242","journal-title":"Eur J Cancer"},{"key":"4931_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","volume":"34","author":"MT Galgano","year":"2010","unstructured":"Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH (2010) Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 34:1077\u20131087. https:\/\/doi.org\/10.1097\/PAS.0b013e3181e8b2c4","journal-title":"Am J Surg Pathol"},{"key":"4931_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/dc.20922","volume":"36","author":"H Lee","year":"2008","unstructured":"Lee H, Lee KJ, Jung CK, Hong JH, Lee YS, Choi YJ, Lee KY, Park G (2008) Expression of HPV L1 capsid protein in cervical specimens with HPV infection. Diagn Cytopathol 36:864\u2013867. https:\/\/doi.org\/10.1002\/dc.20922","journal-title":"Diagn Cytopathol"},{"key":"4931_CR18","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1097\/PAS.0b013e3181709fbf","volume":"32","author":"G Negri","year":"2008","unstructured":"Negri G, Bellisano G, Zannoni GF, Rivasi F, Kasal A, Vittadello F, Antoniazzi S, Faa G, Ambu R, Egarter-Vigl E (2008) p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri. Am J Surg Pathol 32:1715\u20131720. https:\/\/doi.org\/10.1097\/PAS.0b013e3181709fbf","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4931_CR19","first-page":"107","volume":"13","author":"L Zheng","year":"2016","unstructured":"Zheng L, Wu Y, Wang Y (2016) Clinical significance of HPV DNA and HPV L1 protein detection in cervical exfoliated cells. China Med Heral 13(5):107\u2013110","journal-title":"China Med Heral"},{"key":"4931_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3802\/jgo.2008.19.3.16228","volume":"19","author":"JW Kim","year":"2008","unstructured":"Kim JW, Hong JW, Jang HS, Lee SY, Jang SY, Lee DW, Kim SW, Kim JH, Kim YT, Kim S, Kim JW (2008) Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol 19:162\u2013168. https:\/\/doi.org\/10.3802\/jgo.2008.19.3.16228","journal-title":"J Gynecol Oncol"},{"key":"4931_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"R Klaes","year":"2001","unstructured":"Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276\u2013284","journal-title":"Int J Cancer"},{"issue":"1","key":"4931_CR22","first-page":"33","volume":"38","author":"PL Cheah","year":"2016","unstructured":"Cheah PL, Koh CC, Nazarina AR, Teoh KH, Looi LM (2016) Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in situ hybridization in cervical squamous neoplasia. Malays J Pathol 38(1):33\u201338","journal-title":"Malays J Pathol"},{"key":"4931_CR23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/dc.21258","volume":"38","author":"MZ Huang","year":"2010","unstructured":"Huang MZ, Li HB, Nie XM et al (2010) An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions. Diagn Cytopathol 38:573\u2013578","journal-title":"Diagn Cytopathol"},{"key":"4931_CR24","volume-title":"Cervix cancer screening. IARC handbook of cancer prevention","author":"International Agency for Research on Cancer","year":"2005","unstructured":"International Agency for Research on Cancer (2005) Cervix cancer screening. IARC handbook of cancer prevention. IARC, Lyon"},{"key":"4931_CR25","volume-title":"European guidelines for quality assurance in cervical cancer screening","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Antilla A, Jordan J, Ronco G, Schenck U, Segnan N et al (2008) European guidelines for quality assurance in cervical cancer screening, 2nd edn. Office for Official Publications of the European Communities, Luxembourg","edition":"2"},{"key":"4931_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","volume":"26","author":"R Klaes","year":"2002","unstructured":"Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26:1389\u20131399","journal-title":"Am J Surg Pathol"},{"key":"4931_CR27","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","volume":"285","author":"MH Stoler","year":"2001","unstructured":"Stoler MH, Schiffman M (2001) Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study. JAMA 285:1500\u20131505","journal-title":"JAMA"},{"key":"4931_CR28","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ygyno.2010.01.025","volume":"117","author":"J Cuzick","year":"2010","unstructured":"Cuzick J (2010) Long-term cervical cancer prevention strategies across the globe. Gynecol Oncol 117:S4\u2013S11","journal-title":"Gynecol Oncol"},{"key":"4931_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4103\/0300-1652.144706","volume":"55","author":"H Ayatollahi","year":"2014","unstructured":"Ayatollahi H, Homaei-Shandiz F, Kooshyar MM, Tabatabaee-Yazdi SA, Mehrjerdian M, Jafarian AH et al (2014) Human papilloma virus 16\/18 genotypes in patients with squamous cell carcinoma of cervix in northeast Iran. Niger Med J 55:495\u2013498","journal-title":"Niger Med J"},{"key":"4931_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13027-015-0038-5","volume":"10","author":"M Lagos","year":"2015","unstructured":"Lagos M, Van De Wyngard V, Poggi H, Cook P, Viviani P, Barriga MI et al (2015) HPV16\/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile. Infect Agent Cancer 10:43","journal-title":"Infect Agent Cancer"},{"key":"4931_CR31","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10552-014-0406-2","volume":"25","author":"AC Vidal","year":"2014","unstructured":"Vidal AC, Smith JS, Valea F, Bentley R, Gradison M, Yarnall KS et al (2014) HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. Cancer Causes Control 25:1055\u20131062","journal-title":"Cancer Causes Control"},{"key":"4931_CR32","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00404-013-3124-1","volume":"289","author":"N Izadi-Mood","year":"2014","unstructured":"Izadi-Mood N, Sarmadi S, Eftekhar Z et al (2014) Immunohistochemical expression of p16 and HPV L1 capsid proteins as predictive markers in cervical lesions. Arch Gynecol Obstet 289:1287\u20131292","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"4931_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1159\/000325229","volume":"54","author":"W Xiao","year":"2010","unstructured":"Xiao W, Bian M, Ma L et al (2010) Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions. Acta Cytol 54(5):661\u2013667","journal-title":"Acta Cytol"},{"key":"4931_CR34","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1097\/PAS.0b013e3181709fbf","volume":"32","author":"G Negri","year":"2008","unstructured":"Negri G, Bellisano G, Zannoni GF, Rivasi F, Kasal A, Vittadello F, Antoniazzi S, Faa G, Ambu R, Egarter-Vigl E (2008) p16ink4a and HPV L1 immunohistochemistry is helpful for esti-mating the behavior of low-grade dysplastic lesions of the cervix uteri. Am J Surg Pathol 32:1715\u20131720. https:\/\/doi.org\/10.1097\/PAS.0b013e3181709fbf","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4931_CR35","first-page":"241","volume":"26","author":"H Griesser","year":"2004","unstructured":"Griesser H, Sander H, Hilfrich R et al (2004) Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild\/moderate dysplasia. Anal Quant Cytol Histol 26(5):241\u2013245","journal-title":"Anal Quant Cytol Histol"},{"key":"4931_CR36","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.prp.2014.07.007","volume":"210","author":"HA Alshenawy","year":"2014","unstructured":"Alshenawy HA (2014) Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis. Pathol Res Pract 210:916\u2013921","journal-title":"Pathol Res Pract"},{"key":"4931_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ijc.22172","volume":"120","author":"Q Zhang","year":"2007","unstructured":"Zhang Q, Kuhn L, Denny LA et al (2007) Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests. Int J Cancer 120:351\u2013356","journal-title":"Int J Cancer"},{"key":"4931_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/cncy.21205","volume":"120","author":"J Roelens","year":"2012","unstructured":"Roelens J, Reuschenbach M, von Knebel Doeberitz M et al (2012) p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer Cytopathol 120:294\u2013307","journal-title":"Cancer Cytopathol"},{"key":"4931_CR39","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.28485","volume":"134","author":"GD Liao","year":"2014","unstructured":"Liao GD, John W et al (2014) p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China. Int J Cancer 134:1715\u20131724","journal-title":"Int J Cancer"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-018-4931-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T20:07:28Z","timestamp":1720728448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-018-4931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4931"],"URL":"https:\/\/doi.org\/10.1007\/s00404-018-4931-1","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"assertion":[{"value":"25 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}